Global Glaucoma Therapeutics Market to Register Strong Growth with Riding on Strong Pipeline of Combination Drugs
Glaucoma is a widespread condition, affecting millions around the world. According to the World Health Organization (WHO), it is the second most common cause of blindness after cataract. Glaucoma in general occurs as an after-effect of increased intraocular pressure (IOP) caused due to the malfunctioning or abnormality of the eye drainage system. A majority of treatments are targeted to either lower or control the intraocular pressure to prevent damage to the optic nerve that transmits visual stimuli to the brain.
View full press release